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Abstract
A strong positive association between depression and alcoholism is evident in epidemiological
studies. Curiously, the incidence of smoking (nicotine intake) is also very high among depressed
individuals. Because neuronal nicotinic receptors have been implicated in mood regulation as well
as in reinforcing effects of alcohol, it was of interest to determine whether inherent changes in these
receptors may be manifested in an animal model that expresses both depressive-like characteristics
and high alcohol intake. Thus, Fawn-Hooded (FH) rats along with their control ACI rats were used
to measure the density of the high affinity nicotinic receptor in discrete brain regions. Furthermore,
the effects of acute and chronic nicotine on depressive-like characteristics of FH rats were also
evaluated. Measurements of [3H]cytisine binding (selective for α4β2 nicotinic receptor subtype)
revealed a reduction in these receptors only in the striatum of FH rats, a result very similar to that
observed in selectively-bred alcohol-preferring (P) rats. Administration of nicotine acutely (0.4 mg/
kg, sc) resulted in a significant reduction of immobility in the forced swim test (FST) in FH rats only,
implying an antidepressant-like effect of nicotine. Another group of FH rats were administered 0.4
mg/kg nicotine (daily, sc) for 14 days and their behavior in the FST was evaluated 22–24 h after the
last injection. In this case, nicotine also had a significant antidepressant-like effect in FH rats
suggesting no tolerance to nicotine had occurred. The effects of nicotine on FST behavior are very
similar to those observed in Flinders Sensitive Line rats, a putative animal model of depression.
Together, these findings provide additional evidence for antidepressant-like effects of nicotine and
strengthen the postulated association between striatal nicotinic receptors and high alcohol intake.
Thus, nicotinic receptors could be suitable targets for the development of novel pharmacotherapy
for treatment of depression and possibly alcoholism.
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Although significant progress in the pharmacotherapy of depression has been achieved in the
past decades, the refractory cases, delays in response and side effects associated with current
medications are among major medical challenges. Similarly, therapeutic approaches in
treatment of alcoholism are far from ideal and are often complicated by the prevalent co-morbid
occurrence of depression. Thus, understanding the biological substrates that could contribute
to such co-morbidity may offer novel pharmacotherapy. Interestingly, Fawn-Hooded (FH) rats
show both high alcohol intake and depressive characteristics (Rezvani et al., 2002,2007),
rendering them a suitable animal model to investigate neurobiological substrates of co-morbid
alcohol-depression condition. The FH/Wjd strain voluntarily consumes high amounts of
alcohol (Rezvani et al., 1990,2002), shows innate exaggerated immobility in the forced swim
test (Rezvani et al., 2002), and exhibits elevated corticosterone levels that are normalized with
antidepressant treatment (Aulakh et al., 1993). These differences are observed not only in
reference to other strains of rats, such as Wistar and Sprague–Dawley, but also in reference to
other inbred strains, including the FH/Har and ACI strains (Overstreet et al., 1999).
Curiously, the incidence of smoking (nicotine intake) is very high among both alcoholics
(Meyerhoff et al., 2006) and depressed individuals (see reviews: Glassman, 1993, Quattrocki
et al., 2000). Whereas the reinforcing effects of nicotine may contribute to its simultaneous
intake with alcohol (Tizabi et al., 2002, 2007), the postulated antidepressant effects of nicotine
may contribute to its use in depressed individuals. It has been observed that chronic
administration of nicotine or selective nicotinic agonist in the learned helplessness paradigm
in rats may alleviate the depressive symptoms in these rats (Semba et al., 1998, Ferguson et
al., 2000). We have demonstrated that acute or chronic intermittent administration of nicotine
in Flinders Sensitive Line (FSL) rats, an animal model of depression (Overstreet et al.,
2005a), alleviates their depressive symptoms as determined by reduction of their immobility
in the forced swim test (FST) (Tizabi et al., 1999). Similar results were obtained by Djuric et
al. (1999) following chronic oral intake of nicotine in FSL rats. We also observed that FSL rats
had higher nicotinic receptor densities in several brain regions (as determined by [3H]cytisine
binding in tissue homogenate) compared to their control, the Flinders Resistant Line (FRL)
rats (Tizabi et al., 1999). Moreover, the antidepressant effects of nicotine in FSL rats could be
blocked by pretreatment with the non-selective nicotinic receptor antagonist mecamylamine,
strengthening the argument that the antidepressant effects of nicotine are mediated through
nicotinic receptors (Tizabi et al., 2000).
A role for central nicotinic receptors in the reinforcing effects of alcohol has also been
suggested by several animal studies. Thus, administration of mecamylamine either
systemically (Blomqvist et al., 1996; Lê et al., 2000) or into the ventral tegmental area of rats
(Ericson et al., 1998) markedly reduced ethanol intake and preference (see also Soderpalm et
al., 2000; Lof et al., 2007) as well as ethanol-induced dopamine release in the nucleus
accumbens (Tizabi et al., 2002, 2007, Ericson et al., 2008). Moreover, several clinical studies
have reported a decrease in alcohol reinforcing effects following mecamylamine
administration (Blomqvist et al., 2002; Chi and de Wit, 2003). Interestingly, alcohol-preferring
(P) rats show a reduction of the high affinity nicotinic receptors in the striatum (Tizabi et al.,
2001), which is in contrast to the increased number of these receptors seen in FSL rats. In this
study we sought to determine whether high affinity nicotinic receptor densities in FH rats would
resemble those of P or FSL rats. Moreover, it was of relevance to investigate whether nicotine
may also act as an antidepressant in this strain.
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2. Materials and methods
2.1. Animals and housing
The Fawn-Hooded FH/Wjd (FH) and ACI/N (ACI) rats which serve as control model for FH
rats were randomly selected from the breeding colonies maintained by brother–sister mating
at the Center for Alcohol Studies at the University of North Carolina at Chapel Hill. As
mentioned above, the inbred ACI/N strain drinks very little alcohol voluntarily and therefore
is an ideal control for the inbred FH/Wjd rats (Li and Lumeng, 1984; Overstreet et al., 1999).
Adult male rats of approximately 80 days old and weighing 300–350 g were maintained in
groups of 2–3 in plastic cages in a temperature (22 °C) and humidity (50%) controlled room
with free access to food and water and a reversed 12:12 light:dark cycle (lights on at 1900 h).
The reversal of time cycle was to allow convenient measurement of the behavior during active
(dark) phase of the light cycle. The treatment and care of the animals were carried out under
an experimental protocol in accordance with NIH guidelines as approved by the Institutional
Animal Care and Use Committee.
2.2. Forced swim test (FST)
Although the forced swim test was originally developed to test the efficacy of antidepressants,
this test is also commonly used to assess the helplessness or depressive-like behavior in rodents,
particularly those of inbred strains (Porsolt et al., 1977; Detke et al., 1995; Lucki, 1997; Tizabi
et al., 1999; Rezvani et al., 2002; Overstreet et al., 2005a, 2008). This test was conducted in a
cylindrical tank 60 cm tall and 18 cm diameter, containing enough 25 °C water so that the rat
could not touch the bottom with its hind paws. The animal was placed in the water (20 min
after the injection for acute studies, 20–24 h after the last injection for the chronic studies) and
the amount of time it was immobile was recorded over a single 5 min period by an experienced
observer blind to treatment condition. Immediately after the test the animal was dried and
returned to its home cage. It should be mentioned that many studies using the forced swim test
(FST) for screening the antidepressant efficacy of a compound subject the rats to 15 min
“pretest” where the rats are exposed to inescapable water tank as during the 5 min actual test.
This pre-exposure in actuality induces the learned helplessness in that 24 h later the rats
manifest significant amount of immobility against which potential antidepressants are
evaluated. However, FH rats are genetically selected for their manifestation of the behavioral
despair and have been inbred through many generations whereby they may be considered an
inbred animal model of behavioral despair as reflected in their exaggerated immobility in the
FST compared to their control the ACI rats. Thus, the efficacy of an antidepressant may be
evaluated in these animals without the need for pretest. This modified test has been used
repeatedly in our laboratory (e.g., Tizabi et al., 1999; Rezvani et al., 2002; Overstreet et al.,
2005a,b, 2008; Getachew et al., 2008).
Since the biological half-life of nicotine is approximately 90 min, it is unlikely that any nicotine
would be present in the body 20–24 h after the last nicotine injection when the animals were
tested following chronic nicotine administration. Although, the major nicotine metabolite
cotinine may still be present in the plasma due to much longer half-life of this compound, it is
unlikely that the behavioral effects could be attributed to cotinine as it is well established the
major behavioral effects observed following nicotine administration are attributed to nicotine
itself and not its metabolite cotinine (James et al., 1998; Benowitz, 2008; Pehrson et al.,
2008).
2.3. Locomotor activity (LCA) monitoring
In order to exclude the possibility that the differential effect of nicotine in the FST in the FH
and ACI lines could be attributed to any non-specific locomotor effects of nicotine, we
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evaluated the acute effects of nicotine in an open field locomotor activity test. In this test, 20
min after nicotine injection the rats were placed in a monitoring box (60 × 60 cm) that was
divided in 16 squares (10 × 10 cm each) and the number of squares crossed was scored over a
5 min period.
2.4. Drug administration
For acute studies, -(−)nicotine bitartrate (Sigma, St. Louis, US) was dissolved in saline and
was administered subcutaneously (0.1 ml/ 100 g.b.w.). The nicotine dose was adjusted such
that 0.4 mg/kg nicotine base was injected. The animals were tested 20 min after a single
injection. For chronic studies, 0.4 mg/kg nicotine was administered (sc) once daily for 14
consecutive days. In chronic treatments, the swim test was performed 20–24 h after the last
injection. Controls were administered isotonic saline (0.1 ml/100 g. b.w.).
2.5. Tissue collection
Following their adaptation to the housing environment for one week, 8 FH rats and 8 age-
matched ACI rats were decapitated between 10 AM and 2:00 PM. The order of killing was
alternated between the groups. Brains were quickly removed and frozen on dry ice and stored
at −80 °C until dissected and assayed for receptor density.
2.6. Brain dissection and determination of nicotinic receptors
Brains were thawed and kept on an ice-cold plate. Frontal cortex (up to the genu of corpus
callosum and excluding the olfactory bulb and olfactory tubercle), cerebral cortex (the rest of
the cortex, left and right hemisphere), striatum (bilateral), hippocampus (bilateral), midbrain
(containing the thalamus), colliculi (superior and inferior), and cerebellum were dissected as
described previously and stored frozen at −80 °C before measuring nicotinic receptor binding
(Tizabi et al., 1999,2000). Tissue was homogenized in ice-cold 50 mM Tris–HCl buffer (pH
7.0 at room temperature). The tissue homogenate was centrifuged at 38,000 ×g for 12 min at
4 °C. The pellet was washed twice by suspension in fresh buffer and centrifuged again. Aliquots
of homogenate equivalent to approximately 10 to 20 mg tissue were used for determination of
[3H]cytisine binding which is selective for α4β2 nicotinic receptor subtype (Flores et al.,
1992). Approximately 4 nM [3H]cytisine (38.6 Ci/mmol, Perkin-Elmer, Boston, MA) was
incubated in a final volume of 0.25 ml at 2 °C for 75 min. Non-specific binding was obtained
in the presence of 100 μM (−)-nicotine bitartrate. These concentrations used to determine the
maximal receptor binding are based on original description by Pabreza et al. (1991) and a
number of our own previous studies (Tizabi et al., 1999,2000). Membrane-bound [3H]cytisine
was separated from free ligand by filtration in a Brandel cell harvester using Brandel GF/B
filter paper (soaked in 0.5% polyethylenimine to reduce non-specific binding). Samples were
run in triplicate for both total and non-specific binding. Final density was expressed per mg
protein which was determined by using the Pierce BCA kit (Pierce Chemical Company,
Rockford, IL).
2.7. Statistical analysis
Binding data comparing the FH and ACI rats were analyzed by the Student’s t test. Behavioral
parameters were analyzed by two-way ANOVA. The ANOVAs were followed by Newman–
Keuls post hoc test when a significant main effect was indicated. All analyses were two-tailed
and used an alpha of 0.05 or less to determine significance.
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Table 1 presents the [3H]cytisine binding in 7 discrete brain regions of ACI and FH rats.
Binding densities in the two strains were very similar in 6 of the regions. However, in the
striatum the concentration of the high affinity nicotinic receptors was significantly lower
(approximately 27%) in the FH rats compared to ACI (t=2.64, p<0.05).
3.2. Effects of acute nicotine
Compared with their control counterpart, the FH rats demonstrated an enhanced depressive-
like behavior in FST. However, the immobility of FH in FST was significantly F[1,28] = 10.12,
p<0.01 reduced by an acute administration of 0.4 mg/kg nicotine (Fig. 1). The same dose of
nicotine did not have a significant effect on FST in ACI rats. Consistent with the selective
effect of nicotine in the FH rats, the interaction effect was significant (F[1,28] = 12.09, p<0.01).
Interestingly, the 0.4 mg/kg acute nicotine resulted in significant decrease (p<0.01) in the open
field locomotor activity in both FH and ACI rats (Table 2).
3.3. Effects of chronic nicotine
Fig. 2 presents the effects of chronic nicotine administration on swim test immobility in ACI
and FH rats. Administration of nicotine (0.4 mg/kg) for 14 consecutive days resulted in a
significant reduction in swim test immobility in FH rats only. The effects of chronic nicotine
were very similar to those observed in the acute studies suggesting that no tolerance to the
antidepressant-like effects of nicotine developed. Thus, the FH rats were more immobile than
the ACI rats (F[1,28]=4.63, p<0.05) and nicotine had a significant reducing effect on swim
test immobility (F[1,28]=7.04, p<0.01). Again, consistent with nicotine having a selective
effect on the FH rats, the interaction was significant (F[1,28]=9.30, p<0.01).
4. Discussion
The binding studies revealed a significant reduction of the high affinity nicotinic receptors only
in the striatum of FH rats compared to their control, the ACI rats. This finding bears a striking
similarity to what was observed in alcohol-preferring P rats in comparison to the alcohol non-
preferring (NP) rats (Tizabi et al., 2001). Thus, it may be suggested that the shared high intake
for alcohol in P and FH rats is likely to be influenced by a common neurochemical substrate,
i.e. a reduction of high affinity striatal nicotinic receptors. Although a role for nucleus
accumbens shell, part of the ventral striatum, in drugs of abuse including alcohol is well
established (Koob and Bloom, 1988), various other studies indicate also a role for the dorsal
striatum in alcohol consumption (Nestby et al., 1999; Yoshimoto et al., 1999). Given that the
nicotinic receptors are primarily located presynaptically and are known to affect the release of
a variety of neurotransmitters (Wonnacott, 1997), it would be of interest to determine whether
manipulation of striatal nicotinic receptors may influence alcohol intake. Previous studies
reported that nicotine treatment frequently leads to the increase in alcohol intake (Clark et al.,
2001; Lê et al., 2003; Soderpalm et al., 2000) but did not implicate a brain site or specific roles
for selective nicotinic receptor subtype(s). Interestingly, a recent study indicates that
administration of varenicline, a partial agonist at high affinity nicotinic receptor, reduces
alcohol seeking and consumption in rats (Steensland et al., 2007). However, the exact site(s)
of action of varenicline have yet to be identified. It is also of relevance to note that although
several nicotinic receptor subtypes are present in ventral tegmental area the alpha3 containing
subunit may be most directly involved in alcohol rewarding effects (Jerlhag et al., 2006).
In addition to their possible role in alcohol intake and addiction, substantial evidence suggests
involvement of nicotinic receptors in mood regulation and several neuropsychiatric disorders.
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Indeed, an antidepressant-like effect of nicotine has been demonstrated in a variety of animal
(Semba et al., 1998; Ferguson et al., 2000; Djuric et al., 1999; Tizabi et al., 1999, 2000) and
some human studies (Glassman 1993; Salin-Pascual et al., 1996; Gilbert 1996, Salin-Pascual
and Drucker-Colin 1998). Thus, the observed antidepressant-like effects of nicotine in FH rats
in this study further support a role for nicotinic receptors in mood regulation. Nicotine in some
strains of rats that do not manifest exaggerated immobility in the FST may decrease this
immobility (Djuric et al.,, 1999). However, we have found that under present paradigm,
nicotine by itself is not decreasing the immobility in the ACI control rats. This finding is very
similar to what we had observed in FRL rats that act as control for FSL rats (Tizabi et al.,
1999). A possible explanation for our observation in ACI rats is that the immobility in these
animals might be at its trough (floor) level and hence a further reduction in this parameter might
not be easily achieved with nicotine. Moreover, it is important to note that the effects of nicotine
in forced swim test (suggestive of antidepressant-like effect) are not due to a general stimulant
effect of nicotine. Indeed, in this study as well as the previous one with FSL rats, acute nicotine
administration resulted in decreases in locomotor activities in the open field whereas the same
treatment resulted in decreases in immobility in the FST (Table 2 and Tizabi et al., 1999).
A remarkable feature of the FH rats is their dual expression of high alcohol intake and
depressive-like characteristics resembling the co-morbid occurrence of alcoholism and
depression in human populations. Various theories have attempted to explain the association
between alcoholism and depression. These include common genetic susceptibility; an
antidepressant-like effect of alcohol initially that leads to alcohol dependence; or development
of depression following excessive alcohol use (see Getachew et al., 2008). However, the results
of a study with progenies of FH and ACI rats suggest separate genetic controls for the alcohol
intake and depressive-like characteristics in FH rats (Rezvani et al., 2002, 2007). Although
some evidence in support of alcohol-induced depressive-like behavior in animal studies have
been provided (Getachew et al., 2008), there is also evidence that WKY rats, a putative animal
model of depression would consume more alcohol than their control the Wistar rats when given
a free choice (Jiao et al., 2006). Hence, it would be of interest to determine how manipulation
of either behavior (alcohol intake or depressive-like characteristic) of FH rats might affect the
other behavior. Curiously, it was reported recently (Overstreet et al., 2005b) that chronic
treatment with fluoxetine, a well-known antidepressant, resulted in a reduction of swim test
im-mobility but no change in alcohol intake in the FH rats. It should be noted, however, that
distinct neurobiological substrate may be responsible for similar behavior in different species
and hence extrapolation form studies in FH rats to human conditions have to be carefully
considered. Certainly, further elucidation of the complex interaction of nicotine with both
alcohol drinking and depressive-like behavior and involvement of nicotinic receptors in these
interactions is necessary.
5. Conclusion
In summary, these findings indicate that the high affinity nicotinic receptors are reduced in the
striatum of the FH rats similar to what was observed in alcohol-preferring P rats and provide
additional evidence for antidepressant-like property of nicotine in this strain. Further studies
on pharmacotherapy of nicotinic agents and specific role of nicotinic receptors in depression
and alcoholism are warranted.
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Effects of acute nicotine administration (0.4 mg/kg, sc) on swim test immobility in ACI and
FH rats. The animals were tested 20 min after a single injection. Values are means ± SEM,
N = 8/group.
Tizabi et al. Page 10














Effects of chronic nicotine administration (0.4 mg/kg sc daily for 14 days) on swim test
immobility in ACI and FH rats. The animals were tested 20–24 h after the last injection. Values
are means ± SEM, N = 8/group.
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Table 1
[3H]Cytisine binding (fmol/mg protein) in discrete brain regions of ACI and FH rats.
Strain
Region ACI FH







Values are mean±SEM, n=8/group.
*
p<0.05 compared to ACI.
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Table 2





Animals were injected with nicotine (0.4 mg /kg base, sc) and were tested 20 min later in the open field locomotor activity cage.
Values are mean±SEM, n=6/group.
**
p<0.01 compared to vehicle.
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